Our CEO & Co-Founder, Christoph Antz, PhD, will be discussing "Developing the Next Generation of Innovations in Antibody-Drug Conjugates (ADCs)" as part of the ICR Healthcare Conference Series.
Date: Wednesday, September 30, 2026
Time: 11:00a.m. - 12:00 p.m. EDT
The session will bring together some of the leading voices in biopharma to explore the latest developments in ADCs and where they're heading, including how these therapies can reshape the field.
Register to attend here: https://icr.swoogo.com/adc/begin